rosea possesses antioxidant and mitochondrial-protective properties, effectively scavenging reactive oxygen species (ROS), stabilizing mitochondrial membrane potential, and augmenting adenosine triphosphate (ATP) synthesis, which collectively uphold neuronal bioenergetics during conditions of physiological stress (57)
Peptides like BPC-157 and Retatrutide are not FDA approved
doi: 10.1016/j.scienta.2021.110385 47 QuevalG.NoctorG
Treatment of Primary Carnitine Deficiency Treatment of primary carnitine deficiency patients with dietary carnitine supplementation (100400 mg/kg/day) has been shown to be highly beneficial, particularly if started before irreversible organ damage occurs
Given CHEs multidimensional burden, optimal diagnosis and treatment strategies to control the chronic signs and symptoms of disease are essential (Fig
61 Although currently pursued primarily in oncology, these agents may ultimately enable more refined autophagy modulation in cardiovascular settings
